Skip to Main Content
Jue Wang, M.D.

Jue Wang, M.D.

Titles and Appointments

Professor

School
Graduate School
Department
Internal Medicine
Graduate Programs
Biological Chemistry

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Jue Wang, M.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Hematology and Oncology. He specializes in treating patients with bladder, kidney, prostate, penile, and testicular cancer.

    Dr. Wang holds a master's degree in biochemistry from Suzhou Medical College in China, where he also received his medical degree. He completed internal medicine residency training at the University of Texas Medical Branch at Galveston (UTMB), followed by a fellowship in medical oncology. He received advanced cancer research training at the Institute of Cancer Research and Royal Marsden Hospital in England, as well as at the Sealy Center for Molecular Hematology and Oncology at UTMB.

    Certified in internal medicine and medical oncology by the American Board of Internal Medicine, he joined the UT Southwestern faculty in 2023. Previously, he served as Professor of Medicine and Interdisciplinary Oncology at the University of Arizona and Porefessor of Medicine at Creighton University.

    Dr. Wang’s research interests focus on the understanding the molecular mechanisms that underlie advanced genitourinary cancer and developing new strategies that improve the effectiveness of cancer treatments and prevent or reduce treatment-related toxicity. He also conducts studies on the processes and patterns of decision making by oncologists and patients, with the goal of optimizing patient-centered care.

    His investigations have resulted in 120 publications in peer-reviewed journals and contributions to several medical textbooks related to the field of cancer medicine and infection. Dr. Wang is also a co-inventor of Genomic Patient Intelligence (GPI), an electronic health record-based solution that allows clinicians to collect, store, and integrate genomics information to enhance precision medicine decision-making and delivery of personalized cancer therapies.

    Dr. Wang is a Fellow of the American College of Physicians and an active member of several other professional organizations, including the American Society of Clinical Oncology and the American College of Physicians. He also serves as Editor-in-Chief of the Journal of Tumor Research, Annals of Men’s Health and Wellness, and the Journal of Molecular Cancer, as well as the Prostate Cancer Section Editor for Advances in Oncology.

    Dr. Wang has received numerous awards for patient care and for his achievements in teaching and research. In 2020 he received the Faculty Service Award from the University of Arizona College of Medicine; in 2022 he received the Silver Certification of Excellence from the National Cancer Institute and the Certificate of Excellence in Clinical Research from the SWOG Cancer Research Network.

    Personal Note

    Outside of medicine, Dr. Wang's interests include spending time with his family, cooking, reading, and learning to play piano.

  • Education
    Medical School
    Soochow Medical College (1990)
    Other Post Graduate Training
    Soochow Medical College- Master degree of Biochemistry (1993)
    Fellowship
    University of Texas Medical Branch (2002), Hyperbaric Medicine
    Residency
    University of Texas Medical Branch at Galveston (2005), Internal Medicine
    Fellowship
    University of Texas Medical Branch (2007), Medical Oncology
  • Research Interest
    • Clinical and Translational Research of Genitourinary Malignancies
    • Underlying Mechanisms of Cancer Treatment-Related Toxicities
  • Publications

    Star Featured Publications

    Impact of insurance status on testicular cancer outcomes: A single-institution, dual-site study
    Ibezue IC, Khene ZE, Bhanvadia R, Lotan Y, Margulis V, Woldu S, Meng X, Bagrodia A, Arafat W, Wang J, Awan F, Gaston K, Tachibana I. Urol Oncol 2025 12.005 12 Epub ahead of print. PMID: 41469292.
    Real-world treatment outcomes in patients with Ga68-PSMA-PET positive metastatic hormone-sensitive prostate cancer with or without conventional imaging correlates
    Issa W, Aliru M, Zhang S, Gunenc D, Jiang C, Qin Q, Cole S, Arafat W, Wang J, Yang D, Desai N, Garant A, Hannan R, Oz OK, Woldu S, Lotan Y, Roehrborn C, Courtney K, Wang AZ, Zhang T. Clin Genitourin Cancer. 2025 1 24 102476.
    Novel Combination of Metronomic Cyclophosphamide and Darolutamide Induces Sustained Clinical Response in Heavily Treated Prostate Cancer with Prostate-Specific Membrane Antigen-Negative Liver Metastases and Rapid Disease Progression
    Patel VM, Cai Q, Ahn R, Hill K, Wang J. Case Rep Oncol. 2025 1 19 1-8
    Belzutifan and transarterial embolization for symptomatic vaginal metastasis from renal cell carcinoma: a case report.
    Attia, S., Gray, Z., Cai, Q., Kalva, S., Choudhary, M.M., Wang, J. The Journal of Urology Open Plus 2025 12 3 e00151
    Radiation-Associated Aortocolonic Fistula in Urothelial Carcinoma: Multidisciplinary Management and Case Report.
    Lee M, Pillai AK, Fan C, Cai Q, Baker K, Wang J. Clin Case Rep. 2025 10 13 e71247
    Clinical Outcomes of Patients With Metastatic Prostate Cancer With Microsatellite Instability Treated With Pembrolizumab.
    Lambert N, Moore C, Klavon J, Arafat W, Wang J, Zhang T, Courtney K. Clin Genitourin Cancer. 2025 Epub 2025 Jun 14. PMID: 40700962.
    Concurrent Renal Cell Carcinoma Diagnosis in a Married Couple: Risk Factors and Unmet Survivorship Needs.
    Lee M, Jia L, Ahn R, Wang J. Cureus 2025 5 17 e83528. doi: 10.7759/cureus.83528.
    Managing elderly patients with dual metastatic cancers-navigating diagnostic and treatment challenges.
    Gray Z, Levonyak N, Jia L, Ahn R, Balani J, Wang J. Oncologist 2025 3 30 doi: 10.1093/oncolo/oyaf026.
    Pembrolizumab-Induced Myasthenia Gravis With Myocarditis in the Setting of Metastatic Renal Cell Carcinoma.
    Taboada P, Lee M, Hoyer R, Gray Z, Wang J, Cureus 2024 Aug 16 8 e68318
    On reactive Ion Etching of Parylene-C with Simple Photoresist Mask for Fabrication of High Porosity Membranes to Capture Circulating and Exfoliated Tumor Cells.
    Rabadi I, Carpentieri D, Wang J, Zenhausern F, Gu J, Micromachines (Basel) 2024 Apr 15 4
  • Honors & Awards
    • Certificate of Excellence in Clinical Research
      SWOG Cancer Research Network (2022)
    • Silver Certification of Excellence for Exceptional Achievement in Patient Enrollments
      National Cancer Institute (2022)
    • Top Arizona Hematologist-Oncologist
      Waiting Room Magazine (2022)
    • Top Doctors of Arizona
      Modern Luxury Magazine (2022)
    • Top Doctors of Scottsdale
      Modern Luxury Magazine (2022-2023)
    • Faculty Service Award
      University of Arizona College of Medicine (2020)
    • America's Top Doctors - Medical Oncology
      Castle Connolly Medical (2013-2026)
    • Fellow
      American College of Physicians (2011)
    • Educational Award
      International Society of Gastrointestinal Oncology (2007)
  • Professional Associations/Affiliations
    • Alliance for Clinical Trials in Oncology (2011)
    • American College of Physicians (2003)
    • American Medical Association (2003)
    • American Society of Clinical Oncology (2005)
    • American Society of Preventive Oncology (2013)
    • Association of Community Cancer Centers (2014)
    • Connective Tissue Oncology Society (2013)
    • International Association of Oncology (2019)
    • International Society of Gastrointestinal Oncology (2005)
    • International Society of Geriatric Oncology (2006)
    • Society for Basic Urologic Research (2017)